Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23290327 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Ziprasidone;   Drug: Placebo

Indicates status has not been verified in more than two years